Sign Up to like & get
recommendations!
0
Published in 2017 at "Nature Communications"
DOI: 10.1038/s41467-017-00501-y
Abstract: APOBEC3G (A3G) is a human enzyme that inhibits human immunodeficiency virus type 1 (HIV-1) infectivity, in the absence of the viral infectivity factor Vif, through deoxycytidine deamination and a deamination-independent mechanism. A3G converts from a…
read more here.
Keywords:
apobec3g;
dna;
dimerization regulates;
a3g ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Nature Communications"
DOI: 10.1038/s41467-018-04872-8
Abstract: The human APOBEC3G protein is a cytidine deaminase that generates cytidine to deoxy-uridine mutations in single-stranded DNA (ssDNA), and capable of restricting replication of HIV-1 by generating mutations in viral genome. The mechanism by which…
read more here.
Keywords:
crystal structure;
catalytic domain;
apobec3g;
ssdna ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "American Journal of Reproductive Immunology"
DOI: 10.1111/aji.12703
Abstract: APOBEC3G (A3G) is a cytidine deaminase that exhibits antiviral activity by introducing C‐to‐T hypermutation in viral DNA. We recently observed the distinct presence of C‐to‐T hypermutation of human papillomavirus DNA in uterine cervical intraepithelial neoplasia…
read more here.
Keywords:
apobec3g;
intraepithelial neoplasia;
uterine cervical;
progression ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer research"
DOI: 10.1158/0008-5472.can-22-2912
Abstract: Mutagenic processes leave distinct signatures in cancer genomes. The mutational signatures attributed to APOBEC3 cytidine deaminases are pervasive in human cancers. However, data linking individual APOBEC3 proteins to cancer mutagenesis in vivo are limited. Here,…
read more here.
Keywords:
cytidine;
cancer mutagenesis;
apobec3g;
bladder cancer ... See more keywords